Neutrogena T/Gel Alternatives Compared
Neutrogena T/Gel (coal tar) | Stelara (ustekinumab) | Skyrizi (risankizumab) |
|
---|
Neutrogena T/Gel (coal tar) | Stelara (ustekinumab) | Skyrizi (risankizumab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for Seborrheic Dermatitis, Psoriasis, Dermatitis. Neutrogena T/Gel may also be used for purposes not listed in this medication guide. |
Prescription only
Stelara is an immunosuppressant medication that works by binding to two inflammatory cytokines, IL-12 and IL-23, which have been identified as important contributors to chronic inflammation. Stelara... View more |
Prescription only
Skyrizi is an interleukin inhibitor that may be used to treat adults with plaque psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis (UC). The usual dosage is 150mg every 12 weeks... View more |
Related suggestions |
|||||||||||||||
More about Neutrogena T/Gel (coal tar) | More about Stelara (ustekinumab) | More about Skyrizi (risankizumab) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Stelara has an average rating of 7.7 out of 10 from a total of 250 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 15% reported a negative effect. |
Skyrizi has an average rating of 8.1 out of 10 from a total of 51 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Stelara prices |
View all Skyrizi prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other coal tar brands include: Alphosyl, Alphosyl 2 in 1, Amcal Anti Itch Bath Solution, Anti-Dandruff, Apha Keri Tar, Apha Keri Tar Gel, Balnetar, Betatar Gel, Carbo-Dome, Clinitar, Coal Tar Strong, Cutar, DHS Tar Shampoo, Doak Oil Forte, Doak Tar, Doak Tar Oil, Doctar, Eczema Cream, Elta Tar, Estar, Exorex, Exorex Penetrating Emulsion Psoriasis Medication, Fototar, G-TAR, Ionil T, Medotar, MG217 Medicated Tar, MG217 Psoriasis, Neutrogena T/Derm, Neutrogena T/Gel Extra Strength, Oxipor VHC, PC Tar, Psoriasin, Psoriatar, Resolve Itch Cleansing Gel, Scytera, Tarsum, Therapeutic, Theraplex T View more | Other ustekinumab brands include: Imuldosa, Otulfi, Pyzchiva, Selarsdi, Steqeyma, Wezlana, Yesintek |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
N/A |
1291.2 hours |
672 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 6 drugs are known to interact with Neutrogena T/Gel:
|
A total of 529 drugs are known to interact with Stelara:
|
A total of 177 drugs are known to interact with Skyrizi:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
September 25, 2009 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.